Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Here's Why You Should Add Haemonetics (HAE) to Your Portfolio
10:42am, Wednesday, 24'th Mar 2021
Investor are optimistic about Haemonetics (HAE) on its continued Plasma franchise growth and huge potential of Hemostasis Management franchise.
Haemonetics Prices $435.0 Million Convertible Senior Notes Offering
08:22pm, Tuesday, 02'nd Mar 2021
BOSTON, March 2, 2021 /PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $435,000,000 aggregate principal amount of 0.00% Convertible Se
Haemonetics To Present At The Jefferies Plasma Summit
06:50am, Friday, 26'th Feb 2021
BOSTON, Feb. 26, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Jefferies Plasma Summit on Thursday, March 11, 2021, at 10:
Haemonetics: Pure Play On Hematology
07:12am, Monday, 22'nd Feb 2021
Haemonetics: Pure Play On Hematology
Haemonetics (HAE) Q3 Earnings Top Estimates, Margin Contracts
09:06am, Wednesday, 03'rd Feb 2021
Haemonetics (HAE) third-quarter fiscal 2021 revenues declined 7.2% year over year to $240.4 million, improving 14.7% sequentially.
Haemonetics Corporation (HAE) CEO Christopher Simon on Q3 2021 Results - Earnings Call Transcript
11:15am, Tuesday, 02'nd Feb 2021
Haemonetics Corporation (HAE) CEO Christopher Simon on Q3 2021 Results - Earnings Call Transcript
Haemonetics (HAE) Q3 Earnings and Revenues Surpass Estimates
08:20am, Tuesday, 02'nd Feb 2021
Haemonetics (HAE) delivered earnings and revenue surprises of 19.12% and 6.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Haemonetics Q3 Earnings
07:09am, Tuesday, 02'nd Feb 2021
Shares of Haemonetics (NYSE:HAE) were flat in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 13.83% year over year to $0.81, which beat the estimat
Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
06:00am, Tuesday, 02'nd Feb 2021
BOSTON, Feb. 2, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2021, which ended December 26, 2020, are available on its Investo
MedTech Stock Earnings on Feb 2: IDXX, MCK & More
12:07pm, Monday, 01'st Feb 2021
In Q4, MedTech stocks are expected to have gained from month-wise sales rebound in many states and regions. However, international sales might have been dampened.
Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
06:45am, Friday, 22'nd Jan 2021
BOSTON, Jan. 22, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patien
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
06:45am, Wednesday, 20'th Jan 2021
BOSTON, Jan. 20, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patien
Haemonetics (HAE) Hits New 52-Week High: What's Driving It?
11:17am, Monday, 18'th Jan 2021
Haemonetics (HAE) is optimistic about maintaining a robust product portfolio amid the pandemic-led business disruptions.
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2021 Results: February 2, 2021
05:03pm, Tuesday, 05'th Jan 2021
BOSTON, Jan. 5, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2021 financial results at 6:00 am EDT on Tuesday, Febru
6 Stocks Set To Soar In 2021
07:55am, Wednesday, 16'th Dec 2020
With the Covid vaccine rollout accelerating, these companies will be big beneficiaries in the year ahead.
